10 Things Worth Pay...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$88.58 0.49 | 0.56%
06/04/12 - 04:02 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 938.10M | 4.90M | 623.80M | 578.60M |
| Operating Gains/Losses | 5.90M | 15.50M | 31.60M | 138.00M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -105.60M | -71.40M | -17.70M | -114.50M |
| (Increase) Decrease in Inventories | -24.00M | -5.60M | 67.70M | -48.00M |
| (Increase) Decrease In Other Current Assets | -33.10M | -11.30M | -15.40M | 1.70M |
| (Decrease) Increase In Payables | -19.30M | 8.60M | 22.50M | -32.90M |
| (Decrease) Increase In Other Current Liabilities | 19.30M | 11.70M | 56.00M | -11.10M |
| (Increase) Decrease In Other Working Capital | 200.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 107.50M | 476.40M | 169.30M | -5.30M |
| Net Cash From Continuing Operations | 1.08B | 463.90M | 1.11B | 681.90M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 1.08B | 463.90M | 1.11B | 681.90M |
| Sale of Property, Plant & Equipment | 1.20M | 400.00K | 0.00 | 1.20M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 1.14B | 75.00M | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -130.10M | -157.00M | -125.70M | -316.30M |
| Acquisitions | -101.40M | -69.80M | -12.80M | -144.00M |
| Purchases of Short-Term Investments | -571.10M | -824.10M | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | -1.70M | 11.60M | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 340.80M | -977.20M | -98.70M | -459.10M |
| Issuance of Debt | 0.00 | 648.00M | 12.10M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 264.00M | 234.00M | 63.50M | 51.60M |
| Repayment of Long-Term Debt | -808.90M | 0.00 | -98.30M | -34.70M |
| Repurchase of Capital Stock | -461.70M | -286.00M | -105.50M | -230.10M |
| Payment of Cash Dividends | -61.10M | -60.60M | -60.60M | -60.70M |
| Other Financing Charges, Net | 65.40M | 27.60M | 7.30M | 11.10M |
| Net Cash From Financing Activities | -1.00B | 563.00M | -181.50M | -262.80M |
| Effect of Exchange Rate Changes | -5.50M | -5.60M | 3.60M | -7.50M |
| Net Change in Cash & Cash Equivalents | 414.90M | 44.10M | 836.70M | -47.50M |
Portfolios with AGN
- Portfolio NameUser Type
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
- Contributor10 Pharmaceutical Stocks Wi...
- ContributorCramer's Openings in Health...
- ContributorCramer's Vice and Vanity St...
Latest AGN Headlines from TheStreet
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.21.12 | 09:05 am
- Ex-Dividend Stocks: Thomson Reuters, Infosys 05.21.12 | 05:05 am
- Cramer's 'Mad Money' Recap: 7 Stocks to Scoop Up When On Sale 05.09.12 | 08:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Winner 05.03.12 | 05:05 pm
- Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 04:05 pm
- 3 Stocks I Saw on TV, May 2
05.02.12 | 08:05 am - The Week Ahead: Jobs Data; Earnings from MasterCard, Visa, Whole Foods 04.29.12 | 06:04 pm
- Allergan Stock Hits New 52-Week High (AGN) 04.26.12 | 01:04 pm
- 3 Stocks I Saw on TV, April 13 04.13.12 | 08:04 am
- Cramer's 'Mad Money' Recap: Love and Hip Stocks (Final) 04.12.12 | 06:04 pm
Press Releases for AGN
- Allergan Reports First Quarter 2012 Operating Results - Business Wire 05.02.12 | 09:05 am
- BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary Of U.S. Food And Drug Administration Approval - Business Wire 04.13.12 | 09:04 am
- Allergan Announces Quarterly Conference Call - Business Wire 04.06.12 | 01:04 pm
- Allergan Announces Positive Top-Line Results From Phase III BOTOX® Overactive Bladder Program - Business Wire 03.28.12 | 09:03 am
- U.S. Federal Court Finds In Favor Of Allergan, Inc. And Issues Permanent Injunction Against Merz Pharmaceuticals And Merz Aesthetics - Business Wire 03.12.12 | 09:03 am
- Allergan Announces Research & Development Technology Review - Business Wire 02.15.12 | 04:02 pm
- Allergan Reports Fourth Quarter 2011 Operating Results - Business Wire 02.02.12 | 09:02 am
- Allergan Announces Quarterly Conference Call - Business Wire 01.06.12 | 06:01 pm
- Actress Christina Hendricks Urges Women To Join Her In The Final Weeks Of The LATISSE® Wishes Challenge To Increase Money Raised For The Make-A-Wish Foundation® From $390,000 To Campaign Goal Of $500,000 - PR Newswire 11.09.11 | 08:11 am
- Allergan Reports Third Quarter 2011 Operating Results - Business Wire 10.26.11 | 09:10 am
Partner Headlines for AGN
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Cracker Barrel and Other Stocks Insiders Are Buying - Benzinga 04.06.12 | 06:04 am
- Court Deals Blow to Botox Competitor - Analyst Blog - Zacks 03.16.12 | 05:03 pm
- MAP Pharma: Making Money From Migraines - Seeking Alpha 03.11.12 | 09:03 am
- Cramer's Mad Money - 15 Things To Watch This Week (1/27/12) - Seeking Alpha 01.29.12 | 07:01 am
- 6 Drug Companies Favored By Hedge Funds - Seeking Alpha 01.05.12 | 09:01 am
- ETF Showdown: Fun With Pharma - Benzinga 12.30.11 | 04:12 pm
- A Look At Atalanta Sosnoff Capital's Top Buys - Seeking Alpha 11.17.11 | 08:11 am
- Medicis Misses Zacks Consensus - Analyst Blog - Zacks 11.11.11 | 10:11 am
- A Look at The New DRGS ETN - Benzinga 10.31.11 | 01:10 pm
